Prospective tracking of "smoldering" chronic active lesions with notable darkened rims in people with multiple sclerosis (MS), previously only detectable upon autopsy, suggests the lesions are linked ...

Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader, more comprehensive approach to diagnosis, treatment, and research that goes beyond neurologists’ understanding of ...

Treatment with investigational evobrutinib reduced SEL volume compared with placebo, with the highest effect seen with 75 mg twice daily (P=0.047), reported Douglas Arnold, MD, of NeuroRx Research in ...

MONTREAL, Dec. 20, 2018 /PRNewswire/ -- NeuroRx Research () announced today the online release of an Original Research Article published in Multiple Sclerosis Journal and describing a novel method ...

Three new novel treatments have shown promise in the treatment of multiple sclerosis (MS), including the potential to target neuroinflammation at its source. Erik Wallstroem, MD, Phd, Global Head of ...

Emerging science is shaking up what has been previously known about multiple sclerosis (MS), changing our understanding of the basic biology of the disease. For years, the classical picture of MS has ...

Collaborating scientists at the Karolinska Institute and at Stockholm University used a technology called in situ sequencing (ISS) to help reveal at the cellular level how lesions in multiple ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The presence of ...

Treatments for multiple sclerosis have long focused on slowing or stopping the acute disease process, which moves quickly and causes symptom relapses and visible changes on MRI scans. In recent years, ...